Literature DB >> 16984925

Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study.

.   

Abstract

OBJECTIVE: To assess the accuracy of preoperative staging of rectal cancer with magnetic resonance imaging to predict surgical circumferential resection margins.
DESIGN: Prospective observational study of rectal cancers treated by colorectal multidisciplinary teams between January 2002 and October 2003.
SETTING: 11 colorectal units in four European countries. PARTICIPANTS: 408 consecutive patients presenting with all stages of rectal cancer and undergoing magnetic resonance imaging before total mesorectal excision surgery and histopathological assessment of the surgical specimen. MAIN OUTCOME MEASURES: Accuracy of magnetic resonance imaging in predicting a curative resection based on the histological yardstick of presence or absence of tumour at the margins of the specimen.
RESULTS: 354 of the 408 patients had a clear circumferential resection margin (87%, 95% confidence interval 83% to 90%). Specificity for prediction of a clear margin by magnetic resonance imaging was 92% (327/354, 90% to 95%). High resolution scans were technically satisfactory in 93% (379/408). Surgical specimens were histopathologically graded as complete or moderate in 80% (328/408), and the median lymph node harvest was 12 (range 0-49). Magnetic resonance imaging predicted clear margins in 349 patients. At surgery 327 had clear margins (94%, 91% to 96%).
CONCLUSION: High resolution magnetic resonance imaging accurately predicts whether the surgical resection margins will be clear or affected by tumour. This technique can be reproduced accurately in multiple centres to predict curative resection and warns the multidisciplinary team of potential failure of surgery, thus enabling selection of patients for preoperative treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16984925      PMCID: PMC1602032          DOI: 10.1136/bmj.38937.646400.55

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  32 in total

1.  Sample size tables for exact single-stage phase II designs.

Authors:  R P A'Hern
Journal:  Stat Med       Date:  2001-03-30       Impact factor: 2.373

2.  Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer.

Authors:  A Wibe; P R Rendedal; E Svensson; J Norstein; T J Eide; H E Myrvold; O Søreide
Journal:  Br J Surg       Date:  2002-03       Impact factor: 6.939

3.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

4.  Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.

Authors:  M Mohiuddin; W F Regine; W J John; P F Hagihara; P C McGrath; D E Kenady; G Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-01       Impact factor: 7.038

5.  Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?

Authors:  Suzannah Mawdsley; Rob Glynne-Jones; Juliet Grainger; Paul Richman; Andreas Makris; Mark Harrison; Richard Ashford; Richard A Harrison; Melanie Osborne; Jeremy I Livingstone; Peter MacDonald; Ian C Mitchell; John Meyrick-Thomas; John M A Northover; Alastair Windsor; Richard Novell; Marina Wallace
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-11-01       Impact factor: 7.038

6.  Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control.

Authors:  Iris D Nagtegaal; Cornelis J H van de Velde; Erik van der Worp; Ellen Kapiteijn; Phil Quirke; J Han J M van Krieken
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

7.  The modern abdominoperineal excision: the next challenge after total mesorectal excision.

Authors:  Roger Marr; Kevin Birbeck; James Garvican; Christopher P Macklin; Nicholas J Tiffin; Wendy J Parsons; Michael F Dixon; Nicholas P Mapstone; David Sebag-Montefiore; Nigel Scott; David Johnston; Peter Sagar; Paul Finan; Philip Quirke
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

8.  Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project.

Authors:  A L Martling; T Holm; L E Rutqvist; B J Moran; R J Heald; B Cedemark
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

9.  Local recurrence of rectal cancer after total mesorectal excision without preoperative radiotherapy.

Authors:  Christiaan P van Lingen; Clark J Zeebregts; Jos J G M Gerritsen; H Jan Mulder; Walter J B Mastboom; Joost M Klaase
Journal:  Int J Gastrointest Cancer       Date:  2003

10.  MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?

Authors:  S Burton; G Brown; I R Daniels; A R Norman; B Mason; D Cunningham
Journal:  Br J Cancer       Date:  2006-02-13       Impact factor: 7.640

View more
  171 in total

1.  Preoperative evaluation of the depth of anal canal invasion in very low rectal cancer by magnetic resonance imaging and surgical indications for intersphincteric resection.

Authors:  Yoshiko Bamba; Michio Itabashi; Shingo Kameoka
Journal:  Surg Today       Date:  2011-11-11       Impact factor: 2.549

Review 2.  Multidisciplinary management in rectal cancer.

Authors:  Asunción Hervás Morón; María Luisa García de Paredes; Eduardo Lobo Martínez
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

3.  Assessing outcomes following surgery for colorectal cancer using quality of care indicators.

Authors:  Omar Vergara-Fernandez; Carol J Swallow; J Charles Victor; Brenda I O'Connor; Robert Gryphe; Helen M MacRae; Zane Cohen; Robin S McLeod
Journal:  Can J Surg       Date:  2010-08       Impact factor: 2.089

Review 4.  Evolution of imaging in rectal cancer: multimodality imaging with MDCT, MRI, and PET.

Authors:  Siva P Raman; Yifei Chen; Elliot K Fishman
Journal:  J Gastrointest Oncol       Date:  2015-04

5.  MRI in predicting curative resection of rectal cancer: does post-neoadjuvant MRI have a role?

Authors:  Durgesh S Raje
Journal:  BMJ       Date:  2006-10-14

6.  MRI in predicting curative resection of rectal cancer: new dilemma in multidisciplinary team management.

Authors:  R J Heald; Brian D P O'Neill; Brendan Moran; Gina Brown; Ara W Darzi; Andrew C Wotherspoon; David Cunningham; Diana M Tait
Journal:  BMJ       Date:  2006-10-14

7.  MRI can be used to assess advanced T-stage colon carcinoma as well as rectal carcinoma.

Authors:  Akitoshi Inoue; Shinichi Ohta; Norihisa Nitta; Masahiro Yoshimura; Tomoharu Shimizu; Masaji Tani; Ryoji Kushima; Kiyoshi Murata
Journal:  Jpn J Radiol       Date:  2016-10-18       Impact factor: 2.374

Review 8.  Advances and challenges in treatment of locally advanced rectal cancer.

Authors:  J Joshua Smith; Julio Garcia-Aguilar
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

9.  Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions.

Authors:  Paul Hermanek; Susanne Merkel; Rainer Fietkau; Claus Rödel; Werner Hohenberger
Journal:  Int J Colorectal Dis       Date:  2009-12-10       Impact factor: 2.571

10.  MRI staging of low rectal cancer.

Authors:  Oliver C Shihab; Brendan J Moran; Richard J Heald; Philip Quirke; Gina Brown
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.